efgartigimod
-
David Putrino wants to trial Efgartigimod for a subgroup of patients with Long Covid
At the Icahn School of Medicine at Mount Sinai, the neuroscientist and long COVID expert David Putrino is collecting blood samples from some of the patients who responded well to Vyvgart. He hopes the samples could enable better immune phenotyping so clinicians can predict whether a person with...- Formerhuman
- Thread
- autoantibodies efgartigimod long covid small fiber neuropathy
- Replies: 1
- Forum: Long Covid news
-
Medscape: FDA Approves New Myasthenia Gravis Drug
The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with generalized myasthenia gravis (gMG) who test positive for the antiacetylcholine receptor (AChR) antibody... Full text at...- ME/CFS Science Blog
- Thread
- antibodies argenx drug trial drugs efgartigimod fda igg myasthenia gravis vygart
- Replies: 3
- Forum: Other health news and research